国际标准期刊号: 2161-119X

耳鼻喉科:开放获取

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Efficacy of Muscle Relaxants in Routine Treatment Protocol of OSMF and Regional Epidemiological

Gajanan Namdeorao Chavan*

Oral submucous fibrosisis a chronic disorder presenting with the plaguing symptoms of burning sensation in mouth, intolerance to spicy food and progressive trismus. OSMF is insidious in onset characterized by fibrosis of the lining mucosa of the upper digestive tract involving the oral cavity, oropharynx and hypopharynx and the upper third of oesophagus. The fibrosisinvolves the lamina propria and the submucosa and may extend into the underlying musculature resulting in the deposition of dense fibrous bands, resulting in limited mouth opening. It is widely prevalent in all age groups and across all socioeconomic strata in India. OSMF is etiologically related to chewing of areca nut [betel nut] and its commercial products, a habit prevalent in India and South-East Asia. This increaing prevalence is not only our concern but its treatment challenges is also our concern. Though a benign disease, the frequency of malignant change in patients with OSMF ranges from 3% to 6%. We have various established treatment modalities available, medical and surgical both. But the results vary. Hence after understanding its etiopathogenesis and reviewing various treatment modalities, we planned to carry out the study to find out the efficacy of muscle relaxants to treat OSMF.